AGP Executive Report
Last update: 10 hours agoCBD Research & Health: A new review in the Journal of Psychopharmacology reports cannabidiol shows no significant benefit for treating psychotic disorders, urging patients and clinicians to treat CBD as experimental rather than proven. Clinical CBD Product Pipeline: Argent BioPharma struck a global licensing deal for CannEpil with Splash Beverage Group, with ~$5.5M upfront via convertible debt forgiveness and a 15% royalty on global revenue. Regulation & Hemp Retail Pressure: Wisconsin’s intoxicating hemp product ban is set to take effect in November, threatening jobs at a local hemp store; in Tennessee, Democrats are reviving “Pot for Potholes” as hemp restrictions tighten. Medical Cannabis Access: Nebraska’s medical cannabis grower says a county zoning dispute and stop-work order delayed cultivation plans. Local Market Moves: Nanaimo council advanced a proposal for a new cannabis retail shop, while Fort Huachuca placed several local CBD/cannabis-related businesses off-limits to military personnel. Industry Business Signals: A dispensary loyalty platform relaunch in Vallejo helped drive $11,000+ per month in attributed revenue and boosted local search rankings.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
